Giving men with stage IIA and IIB testicular seminoma a single dose of chemotherapy along with radiotherapy may help improve the effectiveness of treatment.

In addition, this new treatment regimen may help reduce the risk of long-term side effects.

John Schieszer has the story in today’s Medical Minute.